Literature DB >> 24680227

Extreme nonresponse to acute phase cognitive therapy for depression: an attempt to replicate and extend.

Aaron M Koenig1, Robin B Jarrett2, Robert Gallop3, Marna S Barrett4, Michael E Thase5.   

Abstract

As with other interventions for major depressive disorder (MDD), cognitive therapy (CT) results in treatment failure for about half of all participants. In 2007, Coffman and colleagues in Seattle studied this topic by identifying a group of patients who demonstrated an extremely poor response to CT (i.e., posttreatment BDI score≥31). They called these patients "extreme nonresponders" (ENR) and described the pretreatment characteristics that predicted response status. In the current study, we attempt a replication of the Seattle study with a larger sample of adults with recurrent MDD (N=473) who received a 16-20 session (12-14week) course of CT. The rate of ENR in this large sample was only 6.3% (30/473), compared to 22.2% (10/45) in the Seattle sample. Four pretreatment measures of symptom severity and functioning differed significantly among ENR and non-ENR participants. In each case, higher symptoms or poorer functioning were associated with ENR status. However, the combination of these factors in a regression model did not predict actual ENR status with the high degree of sensitivity or specificity observed in the Seattle study. These findings suggest that extreme nonresponse to CT is not as common as previously described and, although poor outcomes are associated with pretreatment clinical status, it is difficult to predict posttreatment symptom severity with a high degree of accuracy across different research samples.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  cognitive therapy (CT); major depressive disorder (MDD); nonresponse; predictors of response

Mesh:

Year:  2013        PMID: 24680227      PMCID: PMC4221276          DOI: 10.1016/j.beth.2013.12.005

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  28 in total

1.  Stability, reliability, and norms for the inventory of interpersonal problems.

Authors:  Lucinda E Woodward; Stanley A Murrell; Robert F Bettler
Journal:  Psychother Res       Date:  2005-07

2.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

3.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

4.  The structure, validity and clinical relevance of the Inventory of Interpersonal Problems.

Authors:  M Barkham; G E Hardy; M Startup
Journal:  Br J Med Psychol       Date:  1994-06

5.  Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Authors:  Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

6.  Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables.

Authors:  M W Enns; D K Larsen; B J Cox
Journal:  J Affect Disord       Date:  2000-10       Impact factor: 4.839

7.  Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA.

Authors:  R A Steer; D A Clark; A T Beck; W F Ranieri
Journal:  Behav Res Ther       Date:  1999-02

8.  Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response?

Authors:  Robin B Jarrett; Abu Minhajuddin; Julie L Kangas; Edward S Friedman; Judith A Callan; Michael E Thase
Journal:  Behav Res Ther       Date:  2013-05

9.  The severity of major depression and choice of treatment in primary care practice.

Authors:  H C Schulberg; P A Pilkonis; P Houck
Journal:  J Consult Clin Psychol       Date:  1998-12

10.  Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails?

Authors:  Sandra J Coffman; Christopher R Martell; Sona Dimidjian; Robert Gallop; Steven D Hollon
Journal:  J Consult Clin Psychol       Date:  2007-08
View more
  4 in total

1.  The Role of Dyadic Discord in Outcomes in Acute Phase Cognitive Therapy for Adults With Recurrent Major Depressive Disorder.

Authors:  Joseph M Trombello; Jeffrey R Vittengl; Wayne H Denton; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Journal:  Behav Ther       Date:  2018-12-06

2.  Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.

Authors:  Jeffrey R Vittengl; Robin B Jarrett; Erica Weitz; Steven D Hollon; Jos Twisk; Ioana Cristea; Daniel David; Robert J DeRubeis; Sona Dimidjian; Boadie W Dunlop; Mahbobeh Faramarzi; Ulrich Hegerl; Sidney H Kennedy; Farzan Kheirkhah; Roland Mergl; Jeanne Miranda; David C Mohr; A John Rush; Zindel V Segal; Juned Siddique; Anne D Simons; Pim Cuijpers
Journal:  Am J Psychiatry       Date:  2016-02-12       Impact factor: 18.112

3.  Results from a trial of an unsupported internet intervention for depressive symptoms.

Authors:  Yan Leykin; Ricardo F Muñoz; Omar Contreras; Melissa D Latham
Journal:  Internet Interv       Date:  2014-10-01

4.  Creation and validation of the Cognitive and Behavioral Response to Stress Scale in a depression trial.

Authors:  Adam S Miner; Stephen M Schueller; Emily G Lattie; David C Mohr
Journal:  Psychiatry Res       Date:  2015-10-30       Impact factor: 3.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.